989 related articles for article (PubMed ID: 17140156)
1. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
2. Olfactory involvement in aging and Alzheimer's disease: an autopsy study.
Attems J; Lintner F; Jellinger KA
J Alzheimers Dis; 2005 Apr; 7(2):149-57; discussion 173-80. PubMed ID: 15851853
[TBL] [Abstract][Full Text] [Related]
3. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
Saiz-Sanchez D; Ubeda-Bañon I; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Insausti R; Martinez-Marcos A
Exp Neurol; 2010 Jun; 223(2):347-50. PubMed ID: 19559700
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer pathology in the olfactory bulb.
Jellinger KA; Attems J
Neuropathol Appl Neurobiol; 2005 Apr; 31(2):203. PubMed ID: 15771713
[No Abstract] [Full Text] [Related]
8. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration.
Okazaki K; Fu YJ; Nishihira Y; Endo M; Fukushima T; Ikeuchi T; Okamoto K; Onodera O; Nishizawa M; Takahashi H
Neuropathology; 2010 Apr; 30(2):140-8. PubMed ID: 19780981
[TBL] [Abstract][Full Text] [Related]
9. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
[TBL] [Abstract][Full Text] [Related]
10. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
11. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.
Attems J; Quass M; Jellinger KA
Acta Neuropathol; 2007 Jan; 113(1):53-62. PubMed ID: 17031655
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
13. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
[TBL] [Abstract][Full Text] [Related]
14. CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.
Herukka SK; Hallikainen M; Soininen H; Pirttilä T
Neurology; 2005 Apr; 64(7):1294-7. PubMed ID: 15824371
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Guillozet AL; Weintraub S; Mash DC; Mesulam MM
Arch Neurol; 2003 May; 60(5):729-36. PubMed ID: 12756137
[TBL] [Abstract][Full Text] [Related]
17. Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex.
Katsuno T; Morishima-Kawashima M; Saito Y; Yamanouchi H; Ishiura S; Murayama S; Ihara Y
Neurology; 2005 Feb; 64(4):687-92. PubMed ID: 15728293
[TBL] [Abstract][Full Text] [Related]
18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
19. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
Arch Neurol; 2004 Mar; 61(3):378-84. PubMed ID: 15023815
[TBL] [Abstract][Full Text] [Related]
20. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
